Literature DB >> 15525301

Thrombophilic risk factors and unusual clinical features in three Italian CADASIL patients.

L Pantoni1, C Sarti, F Pescini, S Bianchi, L Bartolini, P Nencini, A M Basile, M Lamassa, R N Kalaria, M T Dotti, A Federico, D Inzitari.   

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a genetically transmitted cerebrovascular disease. Typically, the first clinical manifestation is migraine and the full clinical spectrum of the disease with recurrent strokes of the subcortical type, cognitive, and mood disorders is seen during the fourth and fifth decades of life. Vascular risk factors are usually absent in CADASIL patients and the diagnosis of the disease is particularly suspected in young adults with cerebrovascular events of unknown cause, diffuse leukoencephalopathy on computed tomography or magnetic resonance imaging, and a history of cerebrovascular diseases or dementia in many family members. We describe three Italian CADASIL patients who presented to medical attention for cerebrovascular events occurred after the age of 55 and had, in addition to hypertension and hyperlipidemia, thrombophilic risk factors such as hyperhomocysteinemia, elevated levels of lipoprotein(a), and antiphospholipid antibodies. Symptoms possibly related to cortical involvement, such as dysphasia and visual field deficits, were reported by two of these patients. We conclude that a diagnosis of CADASIL should not be disregarded in patients with vascular risk factors and presenting with symptoms not immediately referable to subcortical damage at ages more advanced than commonly reported.

Entities:  

Mesh:

Year:  2004        PMID: 15525301     DOI: 10.1111/j.1468-1331.2004.00915.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  5 in total

1.  High lipoprotein(a) serum levels in three CADASIL families.

Authors:  Raffaella Valenti; Serena Nannucci; Francesca Pescini; Silvia Bianchi; Domenico Inzitari; Leonardo Pantoni
Journal:  J Neurol       Date:  2011-07-24       Impact factor: 4.849

2.  Clinical and genetic features in a family with CADASIL and high lipoprotein (a) values.

Authors:  Maolian Gong; Franz Rueschendorf; Peter Marx; Herbert Schulz; Hans-Georg Kraft; Norbert Huebner; Hans-Christian Koennecke
Journal:  J Neurol       Date:  2010-02-09       Impact factor: 4.849

3.  First report of a pathogenic mutation on exon 24 of the NOTCH3 gene in a CADASIL family.

Authors:  Raffaella Valenti; Silvia Bianchi; Francesca Pescini; Camilla D'Eramo; Domenico Inzitari; Maria Teresa Dotti; Leonardo Pantoni
Journal:  J Neurol       Date:  2011-03-16       Impact factor: 4.849

Review 4.  Diagnostic criteria for CADASIL in the International Classification of Headache Disorders (ICHD-II): are they appropriate?

Authors:  Simona Sacco; Diana Degan; Antonio Carolei
Journal:  J Headache Pain       Date:  2010-03-12       Impact factor: 7.277

5.  Identification of a known mutation in Notch 3 in familiar CADASIL in China.

Authors:  Zhen-Xuan Tan; Fei-Feng Li; You-Yang Qu; Ji Liu; Gui-Rong Liu; Jin Zhou; Yu-Lan Zhu; Shu-Lin Liu
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.